近年来，随着中国海军力量的迅速发展，尤其是国产航母的接连下水，外界开始关注美国是否在航母领域仍保有对华优势。目前，美国拥有11艘核动力超级航母，全部为10万吨级的尼米兹级和福特级，具备全球部署、高强度作战和舰载机联队规模优势。相比之下，中国现役仅有3艘航母：辽宁舰（改装自苏联设计）、山东舰（国产常规动力）和福建舰（首艘配备电磁弹射系统的国产航母）。尽管福建舰代表了中国航母技术的重大飞跃，但其尚未形成完整战斗力，且在舰载机数量、出动效率、远洋保障能力等方面与美军仍有明显差距。然而，中国在反介入/区域拒止（A2/AD）战略下的导弹、潜艇和卫星侦察体系，对美军航母在西太平洋的行动构成实质性挑战。这意味着即便美国在航母平台本身仍具压倒性优势，但在特定作战环境下，其战术自由度已受到限制。因此，严格来说，美国在航母数量、质量和实战经验上依然领先，但其“绝对优势”正被中国综合海上战力的提升所削弱。未来中美航母竞争将不仅限于舰艇本身，更体现在体系对抗、技术创新与战略部署的全面较量。
In recent years, as China’s navy has rapidly expanded—particularly with the launch of successive domestically built aircraft carriers—questions have arisen over whether the United States still maintains its carrier advantage over China. Currently, the U.S. operates 11 nuclear-powered supercarriers, all Nimitz- or Ford-class vessels displacing around 100,000 tons, offering unmatched global reach, high-intensity combat capability, and large air wings. By contrast, China has three carriers in service: the Liaoning (a refitted Soviet-era hull), the Shandong (China’s first indigenously built conventional carrier), and the Fujian—the first Chinese carrier equipped with an electromagnetic catapult system. Although the Fujian marks a significant technological leap, it has yet to achieve full operational capability, and China still lags behind in aircraft sortie rates, carrier air wing size, and long-range logistical support.That said, China’s anti-access/area-denial (A2/AD) capabilities—including advanced missiles, submarines, and space-based surveillance—pose real challenges to U.S. carrier operations in the Western Pacific. While the U.S. retains overwhelming superiority in carrier platforms themselves, its tactical freedom in regional contingencies is increasingly constrained. Thus, although America still leads in numbers, quality, and combat experience, its once-unquestioned dominance is being eroded by China’s integrated maritime power. The future U.S.-China carrier rivalry will extend beyond ships alone, encompassing integrated systems, technological innovation, and strategic deployment.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/5251.html